The PL Law Group, PLLC
Composition for preventing or treating fracture or osteoporosis using slit-robo system
A pharmaceutical composition for preventing or treating a fracture or osteoporosis, includes, as an active ingredient, a gene selected from a group consisting of slit1, slit2, slit3, robo1, robo2 and vilse, or an expressed protein of the gene. A marker composition for predicting the risk of the occurrence of a fracture or osteoporosis includes the protein. A kit for predicting the risk of the occurrence of a fracture or osteoporosis includes an antibody that specifically binds to the protein. An information provision method for predicting the risk of the occurrence of a fracture or osteoporosis includes measuring the level of expression of the slit protein through an antigen-antibody binding reaction using an antibody that specifically binds to the protein. The slit3 may increase bone formation and decrease bone reabsorption in a cellular and animal model, and has a negative correlation with the incidence rate of osteoporosis.
THE ASAN FOUNDATION
A G A A A G A G A A C G C C A
A61K G01N A61K A61P A61P G01N A23V G01N A61P A23L C07K G01N C07K C07K A61P
additional additional inventional inventional inventional inventional additional inventional inventional inventional inventional additional inventional inventional inventional
Beom-Jun Seung Hun Ghi Su Young-Sun Jung-Min
Kim Lee Kim Lee Koh